Bhatia Sangeeta N. 4

What Happened

• Sangeeta N. Bhatia, a director of Vertex Pharmaceuticals (VRTX), sold 266 shares on 2026-02-13 at $500.00 per share, for total proceeds of $133,000. The sale is recorded as an open-market/private sale (code S).

Key Details

• Transaction date: 2026-02-13; Price: $500.00 per share; Total value: $133,000.
• Shares owned after transaction: Not disclosed in this Form 4.
• Footnote: The sale was made pursuant to a company-approved Rule 10b5-1 trading plan entered into on 2025-05-27.
• Filing: Form 4 was filed on 2026-02-18 (within the required two business days following the transaction, given the Presidents’ Day holiday), so the filing appears timely.

Context

• A 10b5-1 plan indicates the sale was pre-arranged according to a set plan, which is commonly used by insiders to sell shares without contemporaneous trading decisions. Sales are routine insider activity and do not necessarily indicate a change in company outlook; retail investors often view purchases as stronger signals of insider confidence.